Ex Parte Bhagwat et al - Page 5


                Appeal No. 2003-1424                                                  Page 5                  
                Application No. 09/961,623                                                                    

                20 USPQ2d 1438, 1443 (Fed. Cir. 1991) (prima facie obviousness requires, inter                
                alia, motivation to combine and reasonable expectation of success, both founded               
                on the prior art).                                                                            
                      We agree with Appellants that the examiner’s references do not support a                
                prima facie case of obviousness.  The examiner has not adequately explained                   
                why those skilled in the art would have been led to combine Gennaro’s urea with               
                Klein’s anti-acne composition.  Neither Klein nor Gennaro expressly suggest that              
                urea would be effective in treating acne, or that it would impart any other                   
                desirable quality to Klein’s composition.                                                     
                      While Gennaro discloses that urea is a mild keratolytic agent, and                      
                discloses that some other keratolytic agents are useful in treating acne, these               
                disclosures do not support the examiner’s position that it would have been                    
                obvious to combine urea with Klein’s anti-acne composition.  First, Gennaro does              
                not disclose that all keratolytic agents are useful in treating acne.  See pages 767-         
                768:  in the general discussion of keratolytics, Gennaro states only that they are            
                useful for “treatment of epidermophytosis [i.e., fungal infections] . . . [and] to thin       
                hyperkeratotic areas.”  The examiner has not explained how this disclosure would              
                have suggested treatment of acne to those of ordinary skill in the art.                       
                      In addition, Klein teaches away from combining other active agents with its             
                disclosed benzoyl peroxide-containing composition.  See column 2, lines 7-12:                 
                “[B]ecause of the powerful oxidizing properties of the peroxide component, the                
                inclusion of this substance . . . with other active ingredients results in unstable           
                compositions that soon display an unacceptable loss in keratolytic potency.”                  





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007